Published in Women's Health Weekly, March 1st, 2001
"This approval means these women now have a chance of therapy that appears to be useful," said Dr. Terry Allen, a U of A pharmacology professor who developed the treatment. "Every year, 2,500 women in Canada are diagnosed with ovarian cancer and of that number 1,500 will die. Those are the women we are targeting, the ones who would die or are at the advanced stages of the disease."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly